Ackermann Christina
- SEC CIK
- 0001681871
No open-market purchases or sales filed in the past year.
Current role at each company
- VRNA Verona Pharma plcDirectoras of Oct 8, 2025
- CALC CalciMedica, Inc.Directoras of Mar 27, 2023
- BLCO Bausch & Lomb CorpPlease see remarksas of Mar 3, 2023
- BHC Bausch Health Companies Inc.EVP AND GENERAL COUNSELas of Mar 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ackermann Christina as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRNA Verona Pharma plc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Ackermann ChristinaDirector | SSale | −1.81K | $13.14 | −$23.8K | −2.7%64.1K after | |
| May 16, 2025 (view filing) | May 14 | 2 days | Ackermann ChristinaDirector | SSale | −40.0K | $8.44 | −$337.6K | −48.9%41.9K after | 10b5-1 |
| Nov 7, 2024 (view filing) | Nov 6 | 1 day | Ackermann ChristinaDirector | PPurchase | +41.9K | $4.74 | +$198.5K | New position41.9K after |